Hepatitis C (Volume 2) (Biomedical Research Reports, Volume 2) - Tapa dura

"The information provided in this book is a valuable update on the rapidly expanding body of knowledge related to HCV based upon basic and clinical research and would be a valuable addition to the library of individuals in hepatitis C research."
-Betty Robertson, Centers for Disease Control and Prevention for VIRUS RESEARCH (March 2002)
"...this volume is truly deserving of the cliche 'state-of-the-art'. ...the book is encyclopedic in its coverage of all angles of HCV infection, and yet is readable, understandable to the non-expert. ...I believe that this will prove to be a valuable reference text for some years to come."
―W. Irving for JOURNAL OF MEDICAL MICROBIOLOGY (April 2002)
"...an excellent book that details the evolution of hepatitis C from discovery to the present and reflects the "state of the art." A key strength of the book is that each of its 25 chapters is written by a leading expert who has spearheaded research in a particular area from its infancy to the present. ...compiles the most important and relevant information on HCV in one readable reference volume. ...an excellent addition to the personal library of anyone who is working in this area."
-Mary Pat Pauly in PRACTICAL GASTROENTEROLOGY (September 2001)
"an outstanding contribution to the challenging field of HCV [Hepatitis C Virus] infection. The editors have succeeded in their goal to 'illustrate that the marriage between basic science and clinical medicine is paramount in our ultimate success of controlling this global health problem."
-NEW ENGLAND JOURNAL OF MEDICINE (December 2000)

The anticipated encore volume of the Biomedical Research Reports Series, Hepatitis C is the first book that offers comprehensive and up-to-date coverage of this "silent epidemic." The subject matter ranges from basic science to clinical medicine, with contributions from more than 30 international experts in the field. This important new book details the hepatitis C virus and the disease that it causes, including its prevalence, means of spread, symptoms, complications, natural history, prevention, and therapy.
The editors, T. Jake Liang, M.D., and Jay H. Hoofnagle, M.D., are both hepatologists and clinical and laboratory researchers who are well known leaders in the hepatitis field. Their team of authors provide the latest information on key issues such as the role of hepatitis C in liver cancer and evolving therapy for hepatitis C, including special subgroups of patients such as children, patients with renal failure, patients undergoing liver transplantation, and patients with HIV coinfection. The book also addresses future directions in antiviral therapy of hepatitis C and the real challenges of developing a vaccine. Hepatitis C is the integrated reference book for all researchers, clinicians, and students dealing with this troubling virus.

Key Features
* Provides comprehensive coverage of hepatitis C, ranging from basic science to clinical application
* Includes contributions from more than 30 international experts in the field
* Supplies current recommendations on management of hepatitis C
* Designed in an easy-to-use format with consistent organization
* Includes extensive illustrations